Costa BA, Costa TA, Saravia SD, Felix N, et al. Thromboembolic risk of carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for newly diagnosed multiple myeloma: A comparative systematic review and meta-analysis. Am J Hematol 2024 Mar 15. doi: 10.1002/ajh.27288.
PMID: 38488702